Citation Information :
Lalitha T, Balakrishnan A, Parthiban S, Kadhiresan R, Mani E, Sivasankari T. Monocyte-to-High-density Lipoprotein Cholesterol Ratio as a Novel Inflammatory Marker in Periodontal Disease: A Pilot Study. J Contemp Dent Pract 2022; 23 (7):709-712.
Aim: The monocyte-to-high-density lipoprotein cholesterol ratio (MHR) has currently been proposed as an indicator of inflammation. The aim of the present study was to assess the relationship between the monocyte-to-high-density lipoprotein cholesterol ratio and periodontal health and disease.
Materials and methods: A total of 90 patients were selected for the study – 30 healthy patients (group I) and 60 periodontitis patients (groups II and III). All the patients were subjected to blood sampling and serum malondialdehyde (MDA), high-density lipoprotein cholesterol (HDL) levels and monocyte counts were estimated.
Results: Monocyte-to-high-density lipoprotein cholesterol ratio was 80.64 ± 28.71 for patients with moderate periodontitis (group II), 95.14 ± 53.21 in severe periodontitis (group III), and 14.28 ± 16.05 for the healthy patients. Monocyte-to-high-density lipoprotein cholesterol ratio values were found to be statistically significantly higher than the control group (p < 0.001). Monocyte-to-high-density lipoprotein cholesterol ratio also showed significantly positive correlation with the severity of periodontitis.
Conclusion: Malondialdehyde and MHR are increased in periodontal disease and correlate with severity of the periodontal disease.
Clinical significance: Monocyte-to-high-density lipoprotein cholesterol ratio is a novel, readily available inflammatory and oxidative stress marker in patients with periodontitis and can be useful to evaluate periodontitis and disease severity.
Page RC, Offenbacher S, Schroeder HE, et al. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216–248. DOI: 10.1111/j.1600-0757.1997.tb00199.x.
Wei D, Zhang XL, Wang YZ, et al. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy. Aust Dent J 2010;55(1):70–78. DOI: 10.1111/j.1834-7819.2009.01123.x.
Morandini ACF, Sipert CR, Gasparoto TH, et al. Differential production of macrophage inflammatory protein-1alpha, stromal-derived factor-1, and IL-6 by human cultured periodontal ligament and gingival fibroblasts challenged with lipopolysaccharide from P. gingivalis. J Periodontol 2010;81(2):310–317. DOI: 10.1902/jop.2009.090375.
Canpolat U, Çetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost 2016;22(5):476–482. DOI: 10.1177/1076029615594002.
Buhlin K, Gustafsson A, Pockley AG, et al. Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 2003;24(23):2099–2107. DOI: 10.1016/j.ehj.2003.09.016.
Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, et al. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res 2004;45(1):139–147. DOI: 10.1194/jlr.M300250-JLR200.
Monteiro AM, Jardini MAN, Alves S, et al. Cardiovascular disease parameters in periodontitis. J Periodontol 2009;80(3):378–388. DOI: 10.1902/jop.2009.080431.
Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Clin Periodontol 2018;45(Suppl 20):S149–S161. DOI: 10.1111/jcpe.12945.
Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15(2):212–216. DOI: 10.1016/0006-2944(76)90049-1.
Cekici A, Kantarci A, Hasturk H, et al. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014;64(1):57–80. DOI: 10.1111/prd.12002.
Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 2014;20(7):1126–1167. DOI: 10.1089/ars.2012.5149
Ghallab NA, Hamdy E, Shaker OG. Malondialdehyde, superoxide dismutase and melatonin levels in GCF of aggressive and chronic periodontitis patients. Aust Dent J 2016;61(1):53–61. DOI: 10.1111/adj.12294.
Khalili J, Biloklytska HF. Salivary malondialdehyde levels in clinically healthy and periodontal diseased individuals. Oral Dis 2008;14(8):754–760. DOI: 10.1111/j.1601-0825.2008.01464.x.
Enhos A, Cosansu K, Huyut MA, et al. Assessment of the relationship between monocyte to high-density lipoprotein ratio and myocardial bridge. Arq Bras Cardiol 2019;112(1):12–17. DOI: 10.5935/abc.20180253.
Inoue K, Kobayashi Y, Hanamura H, et al. Association of periodontitis with increased white blood cell count and blood pressure. Blood Press 2005;14(1):53–58. DOI: 10.1080/08037050510008869.
Renvert S, Ohlsson O, Pettersson T, et al. Periodontitis: A future risk of acute coronary syndrome? A follow-up study over 3 years. J Periodontol 2010;81(7):992–1000. DOI: 10.1902/jop.2010.090105.
Buhlin K, Hultin M, Norderyd O, et al. Risk factors for atherosclerosis in cases with severe periodontitis. J Clin Periodontol 2009;36(7):541–549. DOI: 10.1111/j.1600-051X.2009.01430.x.
Shaddox LM, Wiedey J, Calderon NL, et al. Local inflammatory markers and systemic endotoxin in aggressive periodontitis. J Dent Res 2011;90(9):1140–1144. DOI: 10.1177/0022034511413928.
Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994;5:112–141. DOI: 10.1111/j.1600-0757.1994.tb00021.x.
Fentoğlu O, Oz G, Taşdelen P, et al. Periodontal status in subjects with hyperlipidemia. J Periodontol 2009;80(2):267–273. DOI: 10.1902/jop.2009.080104.
Cetin MS, Ozcan Cetin EH, Kalender E, et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ 2016;25(11):1077–1086. DOI: 10.1016/j.hlc.2016.02.023.
Vahit D, Akboga MK, Samet Y, et al. Assessment of monocyte to high density lipoprotein cholesterol ratio and lymphocyte-to-monocyte ratio in patients with metabolic syndrome. Biomark Med 2017;11(7):535–540. DOI: 10.2217/bmm-2016-0380.
Yılmaz M, Kayançiçek H. A new inflammatory marker: Elevated monocyte to HDL cholesterol ratio associated with smoking. J Clin Med 2018;10;7(4):76. DOI: 10.3390/jcm7040076.